Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies (vol 74, pg 1216, 2017)

被引：1
|
作者：
Kao, J. C.
Liao, B.
Markovic, S. N.
机构：
来源：
JAMA NEUROLOGY | 2017年 / 74卷 / 10期
关键词：
D O I：
10.1001/jamaneurol.2017.3044
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1271 / 1271
页数：1
相关论文
共 50 条
  • [31] Neurological Adverse Effects Due to Programmed Death (PD-1) Inhibitors
    Shi, Siyu
    Kanwar, Ruhi
    Varanasi, Vamsi
    Eisinger, Ella
    Thomas, Reena
    Moore, Justin
    [J]. NEUROLOGY, 2019, 92 (15)
  • [32] Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors
    Justin C. Kao
    Adipong Brickshawana
    Teerin Liewluck
    [J]. Current Neurology and Neuroscience Reports, 2018, 18
  • [33] Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors
    Kao, Justin C.
    Brickshawana, Adipong
    Liewluck, Teerin
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (10)
  • [34] Cutaneous toxicities of anti-programmed death (anti-PD-1) antibodies in patients with advanced solid organ tumours
    Hwang, S. J. E.
    Wakade, D.
    Byth, K.
    Chou, S.
    Hui, R.
    Gurney, H.
    Fernandez-Penas, P.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 : 61 - 61
  • [35] Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma
    Lee, Joycelyn J. X.
    Chan, Alexandre
    Tang, Tiffany
    [J]. ACTA ONCOLOGICA, 2016, 55 (04) : 519 - 520
  • [36] Clinical Response to Anti-Programmed Death 1 After Response and Subsequent Progression on Anti-Programmed Death Ligand 1 Therapy
    Castellanos, Emily H.
    Feld, Emily
    Estrada, Monica V.
    Sanders, Melinda E.
    Massion, Pierre P.
    Johnson, Douglas B.
    Balko, Justin M.
    Horn, Leora
    [J]. JCO PRECISION ONCOLOGY, 2017, 1
  • [37] Mitochondrial myopathy associated with anti-programmed cell death 1 therapy
    Ibrahim, Tony
    Adam, Clovis
    Routier, Emilie
    Slama, Abdelhamid
    Robert, Caroline
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 110 : 71 - 73
  • [38] Immunological Cytopenias Induced By Anti-Programmed Cell Death (ligand) 1 Antibodies
    Michot, Jean-Marie
    Delanoy, Nicolas
    Comont, Thibault
    Kramkimel, Nora
    Dupont, Romain
    Lazarovici, Julien
    Champiat, Stephane
    Robert, Caroline
    Herbaux, Charles
    Besse, Benjamin
    Chahine, Claude
    Guillemin, Aude
    Mateus, Christine
    Pautier, Patricia
    Saiag, Philippe
    Madonna, Emmanuela
    Maerevoet, Marie
    Bout, Jean-Christophe
    Leduc, Charlotte
    Biscay, Pascal
    Quere, Gilles
    Nardin, Christophe
    Ebbo, Mikael
    Albiges, Laurence
    Marret, Gregoire
    Levrat, Virginie
    Dujon, Cecile
    Laghouati, Salim
    Croisille, Laure
    Voisin, Anne-Laure
    Godeau, Bertrand
    Massard, Christophe
    Ribrag, Vincent
    Marabelle, Aurelien
    Michel, Marc
    Lambotte, Olivier
    [J]. BLOOD, 2018, 132
  • [39] Bullous pemphigoid associated with anti-programmed cell death protein 1 and anti-programmed cell death ligand 1 therapy: A case series of 13 patients
    Yun, Jenny S. W.
    Chan, On Bon
    Goh, Michelle
    McCormack, Christopher J.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (01) : 131 - 137
  • [40] Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients
    Sollini, M.
    Kirienko, M.
    Cozzi, L.
    Torrisi, C.
    Antunovic, L.
    Tabacchi, E.
    Calderoni, L.
    Nanni, C.
    Alessi, A.
    Seregni, E.
    Fanti, S.
    Guidetti, A.
    Ricci, F.
    Corradini, P.
    Zinzani, P.
    Stella, C. Carlo
    Chiti, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S154 - S154
12345